Studies have found that vitamin C can reduce the hospitalization time of severe patients

According to a report by the United States News Agency on March 27, researchers have found that vitamin C can reduce the length of stay in hospital for critically ill patients.

Vitamin C has been proved to reduce the blood pressure and blood sugar level of patients with type 2 diabetes, and also reduce the incidence of atrial fibrillation in such patients. Recently, scientists found that vitamin C can also shorten the hospitalization time of severe patients.

Salad sauce is not always high in calories, and it can be healthy if eaten right

A study published in the March 26 issue of the journal Nutrition showed that patients taking vitamin C orally spent nearly 8% less time in intensive care units and patients taking 2 grams of vitamin on average spent nearly 9% less time in intensive care units.

Since the research conclusions that have been published so far are basically consistent, vitamin C may be applied to the treatment of patients in intensive care units, although this still requires further study on the optimal administration scheme.

Vitamin C is a safe and low-cost essential nutrient. Because patients are in great demand for vitamin C, the amount of vitamin C plasma that hospitals can supply is usually very small.

A healthy person only needs to take 0.1 gram of vitamin C every day, but due to burns, infections, surgery and trauma, severe patients will quickly lose a large amount of vitamin C, which may make them need to take up to 4 grams of vitamin C every day.

However, the researchers said more research was needed to determine which patients could benefit most and the dose they needed.

The author of the study wrote: ” Some studies on the common cold show that there is a linear dose-response relationship between vitamin C dose and the duration of the cold, which is very significant when the daily intake of vitamin reaches 6~8g. The daily vitamin intake of patients in the intensive care unit exceeds 2g, and obviously the dose response of patients should also be studied. “

Leave a Reply

Your email address will not be published. Required fields are marked *